WHO ICTRP trial
PROlonged versus Single dose in PEnicillin oral Challenge Testing-2
ACTRN12624001107516 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12624001107516 |
|---|---|
| Public title | PROlonged versus Single dose in PEnicillin oral Challenge Testing-2 |
| Scientific title | PROlonged versus Single dose in PEnicillin oral Challenge Testing double-blind parallel randomized placebo cOntrolled tRial – PROSPECTOR-2 Study: Evaluating the efficacy of prolonged oral penicillin challenge over single dose oral penicillin challenge to ascertain true penicillin allergy |
| Primary sponsor | Austin Health |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | Australia;Canada;South Africa;Denmark |
| Conditions | allergies;adverse drug reaction;Penicillin allergy;Delayed hypersensitivity; allergies adverse drug reaction Penicillin allergy Delayed hypersensitivity;Inflammatory and Immune System - Allergies |
| Interventions | Amoxicillin 500mg (oral capsule) twice daily for 5 days. Participants will complete study dosing log and return study bottle to trial pharmacy to monitor adherence to protocol |
| Registration date | Sep 13, 2024 |
| Target size | 712 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: